Patents by Inventor Hansen Alexa

Hansen Alexa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators
    Patent number: 7759352
    Abstract: Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: July 20, 2010
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Joseph L. Duffy, Scott Edmondson, Hansen Alexa, Cheng Zhu
  • Substituted Imidazole-4-Carboxamides as Cholecystokinin -1 Receptor Modulators
    Publication number: 20090281117
    Abstract: Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
    Type: Application
    Filed: April 10, 2007
    Publication date: November 12, 2009
    Inventors: Joseph L. Duffy, Scott Edmondson, Hansen Alexa, Cheng Zhu
  • Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators
    Publication number: 20090239862
    Abstract: Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1, such as obesity, and diabetes.
    Type: Application
    Filed: April 10, 2007
    Publication date: September 24, 2009
    Inventors: Richard Berger, Scott Edmondson, Hansen Alexa, Cheng Zhu
  • Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators
    Publication number: 20090118300
    Abstract: Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
    Type: Application
    Filed: April 10, 2007
    Publication date: May 7, 2009
    Inventors: Richard Berger, Scott Edmondson, Hansen Alexa, Cheng Zhu